title: The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome.
authors.affiliation: Department of Rheumatology sean.murphy2@srft.nhs.uk.
authors.forename: Sean M
authors.initials: SM
authors.lastname: Murphy
authors.affiliation: Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford.|NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester.
authors.forename: James B
authors.initials: JB
authors.lastname: Lilleker
authors.affiliation: Section of Musculoskeletal Disease, Chapel Allerton Hospital, University of Leeds, Leeds, UK.
authors.forename: Philip
authors.initials: P
authors.lastname: Helliwell
authors.affiliation: Department of Rheumatology.|NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester.
authors.forename: Hector
authors.initials: H
authors.lastname: Chinoy
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001168:Arthritis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D001691:Biological Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008025:Ligases / Q000037:antagonists & inhibitors*; D017563:Lung Diseases, Interstitial / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D009220:Myositis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011859:Radiography; D013577:Syndrome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D008025:Ligases; C502936:tocilizumab